SCHEMBL10077477

SCHEMBL10077477

CCNc1ccc(C(=O)NCCN)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NFKB1 P19838 2/20 0.60
TSHR P16473 2/20 0.60
CYP1A2 P05177 1/20 0.60
MAOB P27338 1/20 0.60
KMT2A Q03164 3/20 0.58
BLM P54132 3/20 0.58
PMP22 Q01453 2/20 0.58
MEN1 O00255 1/20 0.58
HDAC3 O15379 1/20 0.55
HDAC1 Q13547 1/20 0.55
TERT O14746 2/20 0.50
KDM4E B2RXH2 1/20 0.46
ALDH1A1 P00352 3/20 0.46
KCNH2 Q12809 1/20 0.46
LMNA P02545 3/20 0.45
SLC22A2 O15244 1/20 0.45
SLC22A1 O15245 1/20 0.45
ACHE P22303 1/20 0.45
MAPK1 P28482 1/20 0.45
CYP2C19 P33261 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10294734 0.86 KDM4E (0.57) NFKB1KMT2ABLMHDAC3HDAC1
SCHEMBL10261106 0.84 CA12 (0.49) NFKB1KMT2ABLMMEN1HDAC3
SCHEMBL3861146 0.84 MAOB (0.81) NFKB1TSHRCYP1A2MAOBKMT2A
SCHEMBL749730 0.83 MAOB (0.60) NFKB1TSHRCYP1A2MAOBKMT2A
SCHEMBL751542 0.83 ALDH1A1 (0.57) NFKB1TSHRCYP1A2MAOBKMT2A
SCHEMBL748843 0.82 MEN1 (0.61) NFKB1TSHRCYP1A2MAOBKMT2A
SCHEMBL13092061 0.81 MAOB (0.66) NFKB1TSHRCYP1A2MAOBKMT2A
SCHEMBL958453 0.80 MPO (0.55) CYP1A2KMT2ABLMPMP22MEN1
SCHEMBL11196763 0.80 ALDH1A1 (0.64) NFKB1TSHRCYP1A2MAOBKMT2A
SCHEMBL26197859 0.80 HDAC3 (0.46) NFKB1TSHRKMT2ABLMMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138209-B2 Substituted picolinamides as MAO-B inhibitors useful for treating obesity JENRIN DISCOVERY, INC. (US) 2012-03-20 US disclosed